Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 3 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 12060419

    CD79A chimeric antigen receptors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 13, 2024 · Expires Aug 8, 2044

    granted
  2. US 12053491

    Bispecific OR-gate chimeric antigen receptor responsive to CD19 and CD20

    The Regents of the University of California · Granted Aug 6, 2024 · Expires Aug 1, 2044

    granted
  3. US 12049487

    Universal chimeric antigen receptor T-cell preparation technique

    GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  4. US 12049510

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  5. US 12042543

    Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2

    Northwestern University · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  6. US 12043655

    Constitutively active chimeric cytokine receptors

    Allogene Therapeutics, Inc. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  7. US 12030953

    Chimeric antigen receptors, compositions, and methods

    Regents of the University of Minnesota · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  8. US 12005081

    Chimeric receptors and methods of use thereof

    Senti Biosciences, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  9. US 11999796

    Anti-CD70 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  10. US 11999773

    Anti-BCMA chimeric antigen receptors

    Cartesian Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  11. US 11992519

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2024 · Expires May 23, 2044

    granted
  12. US 11993660

    Chimeric polypeptides and methods of altering the membrane localization of the same

    Cell Design Labs, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  13. US 11980640

    Bicistronic chimeric antigen receptors and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2024 · Expires May 9, 2044

    granted
  14. US 11981739

    Chimeric antigen receptor specific for interleukin-23 receptor

    SANGAMO THERAPEUTICS FRANCE · Granted May 14, 2024 · Expires May 9, 2044

    granted
  15. US 11975063

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2024 · Expires May 2, 2044

    granted
  16. US 11963981

    Chimeric antigen receptor

    AUTOLUS LIMITED · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  17. US 11951131

    Anti-SLAMF7 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  18. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  19. US 11931399

    Compositions and methods for dengue virus chimeric constructions in vaccines

    Takeda Vaccines, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  20. US 11932698

    Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof

    Nanjing Legend Biotech Co., Ltd · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  21. US 11926676

    Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

    CRISPR THERAPEUTICS AG · Granted Mar 12, 2024 · Expires Mar 7, 2044

    granted
  22. US 11896617

    Polynucleotides encoding rituximab-resistant chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  23. US 11890346

    Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein

    Northwestern University · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  24. US 11883432

    Chimeric antigen receptor system with adaptable receptor specificity

    Century Therapeutics, Inc. · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted